SCHEMBL13637357

SCHEMBL13637357

N=C1C=CC=C/C1=N/Nc1cc(-c2ccncc2)ccc1OCCCOc1ccc(CC(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 6/20 0.39
PTPN11 Q06124 2/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
TBXAS1 P24557 1/20 0.36
PPARG P37231 4/20 0.35
PPARD Q03181 4/20 0.35
PPARA Q07869 4/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
LTB4R2 Q9NPC1 4/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
GSK3B P49841 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
MAPK14 Q16539 1/20 0.33
SMO Q99835 1/20 0.33
PLA2G4B P0C869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13441643 0.87 FFAR1 (0.39) LTB4RPTPN11PPARGPPARDPPARA
SCHEMBL13442143 0.85 PPARG (0.38) LTB4RPTPN11PTPN1PTPN6PPARG
SCHEMBL13637199 0.75 LTB4R (0.42) LTB4RPPARGPPARDPPARALTB4R2
SCHEMBL13637279 0.75 PPARD (0.35) PPARGPPARDPPARA
SCHEMBL13637162 0.75 LTB4R (0.40) LTB4RTBXAS1PPARGPPARDPPARA
SCHEMBL13637290 0.73 ALDH1A1 (0.40)
SCHEMBL13442144 0.66 PPARG (0.52) LTB4RPTPN11PTPN1PTPN6PPARG
SCHEMBL5149062 0.64 ABCC4 (0.67) GSK3BRXRARXRBRXRG
SCHEMBL13637285 0.63 PLA2G4B (0.38) LTB4RPPARGPPARDLTB4R2PLA2G4B
SCHEMBL11684213 0.62 PLA2G4B (0.69) LTB4RPTPN11TBXAS1LTB4R2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed